Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Asia Broadband Prepares to Launch Its Second Gold-Backed NFT Collection on the Solana Blockchain and Accelerate Digital Asset Expansion
-
Gold Bull Announces $1 Million Non-Brokered Private Placement
-
Integer to Showcase Recently Acquired Capabilities and New Technologies at MD&M West 2024
-
Pan American Energy Announces Further Drill Results at the Big Mack Lithium Project, Including Intersecting 22.85 m at 1.67% Li2O
-
Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform
-
Infinidat’s InfiniBox® and InfiniGuard® Solutions Named One of the Top 5 Cyber Secure Backup Targets for Enterprises by Storage Analyst Firm DCIG
-
ITW Reports Fourth Quarter and Full Year 2023 Results
-
Windtree Renews Agreement with Chang Gung University for Scientific Collaboration to Further SERCA2a Research
-
Royal Neighbors Launches New Final Expense Product Catering to the Uninsured
-
Blackboxstocks, Inc. Acquisition Target Evtec Aluminium Receives New $67 Million Long Term Supply Contract from Jaguar Land Rover
-
Soleno Therapeutics to Present at Upcoming February Investor Conferences
-
Immuneering Announces Participation in February Investor Conferences
-
Acasti Announces Poster Detailing its GTX-104 STRIVE-ON Trial
-
Aemetis Biogas Completes Construction Funding from $25 million USDA Loan for Aemetis Biogas 1 Dairy Digesters
-
Pervasip Announces Restructuring and Spin-Out
-
WiMi Optimized Cloud Task Scheduling in Cloud Computing Using Group Intelligence Algorithms
-
Denali Therapeutics Announces Presentations on Its Investigational Blood-Brain Barrier (BBB)-Crossing Enzyme Replacement Therapies at the Upcoming 2024 WORLDSymposium™
-
Prime Medicine to Present at Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
Erasca to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
-
NightHawk’s Scorpius BioManufacturing Subsidiary Announces the Promotion of Joe Payne to President and Chief Operating Officer
-
BioAdaptives Announces Low-Cost AI FYO Smartphone App Tracking System to Detect Unwanted Muscle Mass Loss Reported With Obesity Management
-
Perspective Therapeutics Introduces “Pre-Targeting” Theranostic Technology Platform
-
Sensus Healthcare Announces Retirement of Director Samuel O’Rear
-
TransUnion Spoofed Call Protection Wins Juniper Research Gold Award for Best Robocall Mitigation Solution
-
AgEagle Aerial Systems Attends UMEX 2024 Together with FEDS to Showcase eBee VISION and TAC Drones Representing Its First Introduction to the Middle East Market
-
Immuneering Announces Participation in February Investor Conferences
-
Acronis Joins Microsoft Intelligent Security Association (MISA)
-
Compass Diversified Completes Partnership with Leading “Better-for-You” Feminine Care Brand The Honey Pot Company
-
Tourmaline Bio to Present at the Guggenheim Healthcare Talks | 6th Annual Biotechnology Conference
-
For Rare Liver Disease Patients, Care Transitions Pose Yet Another Risk
-
Notice of the Annual General Meeting of UPM-Kymmene Corporation
-
EDAP Announces Completion of Enrollment in Phase 3 Study Evaluating Focal One HIFU Therapy for the Treatment of Deep Infiltrating Rectal Endometriosis
-
Semantix and SPC Grafeno Form Strategic Partnership to Enhance Brazil’s Credit Market
-
Udemy Announces Generative AI Roadmap For Accelerated, Personalized Skills Development
-
Former UN Chief of Commodities joins zenGate Global’s Advisory Board
-
Gran Tierra Energy Inc. Announces Private Offering of an Additional Amount of its 9.500% Senior Secured Amortizing Notes due 2029
-
Earth Alive Acquires Interlube and Completes Simplified Vertical Merger
-
Ibogaine By David Dardashti Shares Insight On New Study By Stanford University
-
Alliance Trust PLC - Net Asset Value
-
Share buybacks in Spar Nord Bank – completion of share buyback programme
-
The Shyft Group Announces Quarterly Dividend
-
Bowlin Travel Centers, Inc. Announces Issuer Tender Offer
-
Fireweed Intersects 14 m True Width of 11.45% Zinc, 5.86% Lead, and 126.3 g/t Silver at the New Tom South Zone
-
Purple Biotech Reaches Recommended Phase 2 Dose for NT219
-
Kelly Announces Fourth-Quarter Conference Call
-
Revive Therapeutics Explores the Use of Bucillamine for Long COVID
-
Parker Reports Fiscal 2024 Second Quarter Results
-
Purple Biotech Reaches Recommended Phase 2 Dose for NT219
-
Hillman Sets Fourth Quarter 2023 Earnings Release and Results Presentation Date
-
Anavex Life Sciences to Announce Fiscal 2024 First Quarter Financial Results on Wednesday, February 7th, 2024
